Intelligence Platform

Patents

Browse 311 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9932564

Recombinant isfahan viral vectors

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919040

Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, metho

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896484

Influenza virus recombinant proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879231

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9850468

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9839685

Methods of inducing human immunodeficiency virus-specific immune responses in a host compr

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9827295

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a re

Regents of the University of Minnesota · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765378

Preparation method of new recombinant antibacterial polypeptide medicine

Creative Trio Biotech (Beijing) Co., Ltd. · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683024

Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protei

United States of America as represented by the Secretary of the Air Force · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9605077

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9598697

Recombinant bacterium to decrease tumor growth

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9587008

Method of producing recombinant vitamin K dependent proteins

APTEVO BIOTHERAPEUTICS LLC · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9580690

Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereo

The Board of Regents of the University of Texas System · Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566314

Extracellular vesicles comprising recombinant lysosomal transmembrane protein

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9545431

Isolated recombinant cDNA

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9481888

Recombinant bacterium and methods of antigen and nucleic acid delivery

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439935

Recombinant rift valley fever (RVF) viruses and methods

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9371375

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359429

Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method

PROTEIN DESIGN LAB, LTD. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340792

Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory response

Northwestern University · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328150

Recombinant polypeptide construct comprising multiple enterotoxigenic Escherichia coli fim

United States of America as represented by the Secretary of the Air Force · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted